SCHEMBL17628384

SCHEMBL17628384

CC(=O)N[C@H]1CCN(c2nc(Cl)nc3cc(Cl)ccc23)C1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKDC P78527 2/20 0.47
CNR2 P34972 4/20 0.47
EGLN1 Q9GZT9 1/20 0.45
OPRM1 P35372 2/20 0.43
OPRD1 P41143 2/20 0.43
OPRK1 P41145 2/20 0.43
OGFRL1 Q5TC84 2/20 0.43
SMPD3 Q9NY59 2/20 0.43
HRH4 Q9H3N8 4/20 0.43
HRH3 Q9Y5N1 2/20 0.43
AKT1 P31749 1/20 0.43
HDAC3 O15379 1/20 0.42
MTOR P42345 1/20 0.42
HDAC1 Q13547 1/20 0.42
HDAC2 Q92769 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
GRIA1 P42261 1/20 0.42
KCNH2 Q12809 1/20 0.42
IRAK4 Q9NWZ3 1/20 0.42
STK4 Q13043 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17628385 1.00 PRKDC (0.47) PRKDCCNR2EGLN1OPRM1OPRD1
SCHEMBL17628084 0.89 SMPD3 (0.46) PRKDCCNR2OPRM1OPRD1OPRK1
SCHEMBL17628086 0.89 SMPD3 (0.46) PRKDCCNR2OPRM1OPRD1OPRK1
SCHEMBL17627941 0.88 SMPD3 (0.48) PRKDCCNR2EGLN1SMPD3HRH4
SCHEMBL17627942 0.88 SMPD3 (0.48) PRKDCCNR2EGLN1SMPD3HRH4
SCHEMBL17628428 0.87 SMPD3 (0.49) PRKDCCNR2SMPD3HRH4
SCHEMBL17628426 0.87 SMPD3 (0.49) PRKDCCNR2SMPD3HRH4
SCHEMBL17628336 0.87 OPRM1 (0.52) PRKDCCNR2EGLN1OPRM1OPRD1
SCHEMBL17628334 0.87 OPRM1 (0.52) PRKDCCNR2EGLN1OPRM1OPRD1
SCHEMBL17628393 0.85 HRH4 (0.57) HRH4HRH3KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170152241-A9 BICYCLIC DERIVATIVE CONTAINING PYRIMIDINE RING, AND PREPARATION METHOD THEREFOR YUHAN CORPORATION (KR) 2017-06-01 US disclosed
EP-3006439-A1 BICYCLIC DERIVATIVE CONTAINING PYRIMIDINE RING, AND PREPARATION METHOD THEREFOR Yuhan Corporation (KR) 2016-04-13 EP disclosed
US-20160090374-A1 BICYCLIC DERIVATIVE CONTAINING PYRIMIDINE RING, AND PREPARATION METHOD THEREFOR YUHAN CORP (KR) 2016-03-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170152241-A9 BICYCLIC DERIVATIVE CONTAINING PYRIMIDINE RING, AND PREPARATION METHOD THEREFOR GPR119, GIPR, P2RY4 PRKDC 4342/4885CNR2 660/4885EGLN1 4341/4885
US-20160090374-A1 BICYCLIC DERIVATIVE CONTAINING PYRIMIDINE RING, AND PREPARATION METHOD THEREFOR GPR119, GIPR, P2RY4 PRKDC 4342/4885CNR2 660/4885EGLN1 4341/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.